Group structure and shareholders
Corporate structure as of December 31, 2023
Scope of consolidation
Bellevue Group AG is the only listed company within the Group. The investment companies we manage, BB Biotech AG and Bellevue Healthcare Trust, are independent companies listed on their respective stock exchanges. The companies consolidated by Bellevue Group are listed, together with information regarding their domicile and share capital and the interest held by the Group, in the notes to the consolidated financial statements, note 6 «Major subsidiaries».
Major shareholders
Based on the notifications received and published by Bellevue Group AG, the following parties hold significant voting rights:
Shareholder or beneficial owner | 31.12.2023 Voting rights held | 31.12.2023 Number of shares held | 31.12.2022 Voting rights held | 31.12.2022 Number of shares held | ||||
Martin Bisang, Küsnacht | 20.43% | 2 750 000 | 20.43% | 2 750 000 | ||||
Hansjörg Wyss, Cambridge MA (USA) | 9.66% | 1 300 000 | 9.66% | 1 300 000 | ||||
Jürg und Manuela Schäppi, Rapperswil-Jona | 9.05% | 1 217 799 | 9.05% | 1 217 799 |
The shareholders Martin Bisang (Küsnacht), as well as Jürg and Manuela Schäppi (Rapperswil-Jona) signed a shareholder agreement on October 25, 2018. Martin Bisang will represent the Group and controls 29.48% of the voting rights by December 31, 2023 (December 31, 2022: 29.48%).
Disclosure notifications are retrievable from the SIX Swiss Exchange website at: https://www.ser-ag.com/en/resources/notifications-market-participants/significant-shareholders.html#/
Cross-shareholdings
There are no cross-shareholdings between Bellevue Group AG or its subsidiaries and other corporations.